Specialty Business Services
Compare Stocks
5 / 10Stock Comparison
ABM vs KELYA vs MAN vs CTAS vs RHI
Revenue, margins, valuation, and 5-year total return — side by side.
Staffing & Employment Services
Staffing & Employment Services
Specialty Business Services
Staffing & Employment Services
ABM vs KELYA vs MAN vs CTAS vs RHI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Business Services | Staffing & Employment Services | Staffing & Employment Services | Specialty Business Services | Staffing & Employment Services |
| Market Cap | $2.36B | $355M | $1.38B | $67.28B | $2.73B |
| Revenue (TTM) | $8.87B | $3.09B | $17.96B | $10.79B | $5.38B |
| Net Income (TTM) | $158M | $-266M | $-13M | $1.90B | $133M |
| Gross Margin | 11.5% | 26.3% | 16.7% | 50.2% | 36.8% |
| Operating Margin | 3.7% | -2.8% | 0.8% | 23.0% | 1.4% |
| Forward P/E | 10.2x | 11.2x | 8.1x | 34.1x | 20.5x |
| Total Debt | $1.69B | $159M | $2.39B | $2.65B | $421M |
| Cash & Equiv. | $104M | $33M | $871M | $264M | $464M |
ABM vs KELYA vs MAN vs CTAS vs RHI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| ABM Industries Inco… (ABM) | 100 | 130.8 | +30.8% |
| Kelly Services, Inc. (KELYA) | 100 | 65.8 | -34.2% |
| ManpowerGroup Inc. (MAN) | 100 | 43.2 | -56.8% |
| Cintas Corporation (CTAS) | 100 | 269.3 | +169.3% |
| Robert Half Interna… (RHI) | 100 | 53.3 | -46.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ABM vs KELYA vs MAN vs CTAS vs RHI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ABM is the #2 pick in this set and the best alternative if valuation efficiency is your priority.
- PEG 0.04 vs CTAS's 2.04
- Lower P/E (10.2x vs 20.5x)
- -18.6% vs RHI's -35.2%
KELYA lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, MAN doesn't own a clear edge in any measured category.
CTAS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 7.7%, EPS growth 16.1%, 3Y rev CAGR 9.6%
- 6.7% 10Y total return vs ABM's 47.0%
- Lower volatility, beta 0.51, Low D/E 56.7%, current ratio 2.09x
- Beta 0.51, yield 0.9%, current ratio 2.09x
RHI ranks third and is worth considering specifically for income & stability.
- Dividend streak 22 yrs, beta 0.91, yield 8.8%
- 8.8% yield, 22-year raise streak, vs ABM's 2.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.7% revenue growth vs RHI's -7.2% | |
| Value | Lower P/E (10.2x vs 20.5x) | |
| Quality / Margins | 17.6% margin vs KELYA's -8.6% | |
| Stability / Safety | Beta 0.51 vs KELYA's 0.96 | |
| Dividends | 8.8% yield, 22-year raise streak, vs ABM's 2.6% | |
| Momentum (1Y) | -18.6% vs RHI's -35.2% | |
| Efficiency (ROA) | 18.7% ROA vs KELYA's -11.3%, ROIC 25.8% vs -4.0% |
ABM vs KELYA vs MAN vs CTAS vs RHI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ABM vs KELYA vs MAN vs CTAS vs RHI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CTAS leads in 3 of 6 categories
MAN leads 1 • ABM leads 0 • KELYA leads 0 • RHI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CTAS leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MAN is the larger business by revenue, generating $18.0B annually — 5.8x KELYA's $3.1B. CTAS is the more profitable business, keeping 17.6% of every revenue dollar as net income compared to KELYA's -8.6%. On growth, CTAS holds the edge at +9.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $8.9B | $3.1B | $18.0B | $10.8B | $5.4B |
| EBITDAEarnings before interest/tax | $431M | -$54M | $236M | $2.9B | $150M |
| Net IncomeAfter-tax profit | $158M | -$266M | -$13M | $1.9B | $133M |
| Free Cash FlowCash after capex | $327M | $66M | -$161M | $1.8B | $267M |
| Gross MarginGross profit ÷ Revenue | +11.5% | +26.3% | +16.7% | +50.2% | +36.8% |
| Operating MarginEBIT ÷ Revenue | +3.7% | -2.8% | +0.8% | +23.0% | +1.4% |
| Net MarginNet income ÷ Revenue | +1.8% | -8.6% | -0.1% | +17.6% | +2.5% |
| FCF MarginFCF ÷ Revenue | +3.7% | +2.1% | -0.9% | +16.5% | +5.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.1% | -100.0% | +7.1% | +9.3% | -5.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -7.2% | -2.1% | +36.2% | +11.0% | -39.6% |
Valuation Metrics
MAN leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 15.5x trailing earnings, ABM trades at a 59% valuation discount to CTAS's 37.9x P/E. Adjusting for growth (PEG ratio), ABM offers better value at 0.05x vs CTAS's 2.27x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.4B | $355M | $1.4B | $67.3B | $2.7B |
| Enterprise ValueMkt cap + debt − cash | $3.9B | $481M | $2.9B | $69.7B | $2.7B |
| Trailing P/EPrice ÷ TTM EPS | 15.52x | -1.36x | -102.90x | 37.95x | 20.32x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.15x | 11.15x | 8.12x | 34.12x | 20.48x |
| PEG RatioP/E ÷ EPS growth rate | 0.05x | — | — | 2.27x | — |
| EV / EBITDAEnterprise value multiple | 9.16x | — | 8.94x | 24.41x | 21.27x |
| Price / SalesMarket cap ÷ Revenue | 0.27x | 0.08x | 0.08x | 6.51x | 0.51x |
| Price / BookPrice ÷ Book value/share | 1.41x | 0.35x | 0.67x | 14.62x | 2.13x |
| Price / FCFMarket cap ÷ FCF | 15.19x | 3.11x | — | 38.29x | 10.25x |
Profitability & Efficiency
CTAS leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CTAS delivers a 42.6% return on equity — every $100 of shareholder capital generates $43 in annual profit, vs $-25 for KELYA. KELYA carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to MAN's 1.16x. On the Piotroski fundamental quality scale (0–9), CTAS scores 9/9 vs MAN's 1/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +8.8% | -24.6% | -0.6% | +42.6% | +10.3% |
| ROA (TTM)Return on assets | +3.0% | -11.3% | -0.1% | +18.7% | +4.7% |
| ROICReturn on invested capital | +7.5% | -4.0% | +5.6% | +25.8% | +4.6% |
| ROCEReturn on capital employed | +8.2% | -4.3% | +6.2% | +29.8% | +5.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 1 | 9 | 4 |
| Debt / EquityFinancial leverage | 0.95x | 0.16x | 1.16x | 0.57x | 0.33x |
| Net DebtTotal debt minus cash | $1.6B | $126M | $1.5B | $2.4B | -$43M |
| Cash & Equiv.Liquid assets | $104M | $33M | $871M | $264M | $464M |
| Total DebtShort + long-term debt | $1.7B | $159M | $2.4B | $2.7B | $421M |
| Interest CoverageEBIT ÷ Interest expense | 3.25x | -12.07x | 1.98x | 24.61x | — |
Total Returns (Dividends Reinvested)
CTAS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTAS five years ago would be worth $19,239 today (with dividends reinvested), compared to $3,449 for MAN. Over the past 12 months, ABM leads with a -18.6% total return vs RHI's -35.2%. The 3-year compound annual growth rate (CAGR) favors CTAS at 14.2% vs RHI's -20.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -4.5% | +15.1% | -0.7% | -9.4% | +1.0% |
| 1-Year ReturnPast 12 months | -18.6% | -18.8% | -24.5% | -21.5% | -35.2% |
| 3-Year ReturnCumulative with dividends | +2.0% | -33.1% | -47.2% | +49.1% | -50.1% |
| 5-Year ReturnCumulative with dividends | -14.5% | -57.3% | -65.5% | +92.4% | -59.4% |
| 10-Year ReturnCumulative with dividends | +47.0% | -32.0% | -31.5% | +671.6% | +9.3% |
| CAGR (3Y)Annualised 3-year return | +0.7% | -12.6% | -19.2% | +14.2% | -20.7% |
Risk & Volatility
Evenly matched — ABM and CTAS each lead in 1 of 2 comparable metrics.
Risk & Volatility
CTAS is the less volatile stock with a 0.51 beta — it tends to amplify market swings less than KELYA's 0.96 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ABM currently trades 75.9% from its 52-week high vs RHI's 55.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.71x | 0.96x | 0.89x | 0.51x | 0.91x |
| 52-Week HighHighest price in past year | $52.94 | $14.94 | $47.34 | $229.24 | $48.54 |
| 52-Week LowLowest price in past year | $36.96 | $7.98 | $25.15 | $165.46 | $21.84 |
| % of 52W HighCurrent price vs 52-week peak | +75.9% | +66.1% | +63.0% | +72.8% | +55.7% |
| RSI (14)Momentum oscillator 0–100 | 55.8 | 59.6 | 53.7 | 39.5 | 54.7 |
| Avg Volume (50D)Average daily shares traded | 513K | 364K | 1.1M | 2.1M | 2.9M |
Analyst Outlook
Evenly matched — ABM and RHI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ABM as "Hold", KELYA as "Buy", MAN as "Hold", CTAS as "Hold", RHI as "Hold". Consensus price targets imply 52.0% upside for KELYA (target: $15) vs 24.4% for ABM (target: $50). For income investors, RHI offers the higher dividend yield at 8.79% vs CTAS's 0.89%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $50.00 | $15.00 | $37.86 | $223.40 | $40.67 |
| # AnalystsCovering analysts | 11 | 5 | 29 | 30 | 25 |
| Dividend YieldAnnual dividend ÷ price | +2.6% | +3.2% | +4.8% | +0.9% | +8.8% |
| Dividend StreakConsecutive years of raises | 36 | 5 | 0 | 3 | 22 |
| Dividend / ShareAnnual DPS | $1.05 | $0.31 | $1.43 | $1.49 | $2.37 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.2% | +3.5% | +2.8% | +1.4% | +3.4% |
CTAS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MAN leads in 1 (Valuation Metrics). 2 tied.
ABM vs KELYA vs MAN vs CTAS vs RHI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ABM or KELYA or MAN or CTAS or RHI a better buy right now?
For growth investors, Cintas Corporation (CTAS) is the stronger pick with 7.
7% revenue growth year-over-year, versus -7. 2% for Robert Half International Inc. (RHI). ABM Industries Incorporated (ABM) offers the better valuation at 15. 5x trailing P/E (10. 2x forward), making it the more compelling value choice. Analysts rate Kelly Services, Inc. (KELYA) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ABM or KELYA or MAN or CTAS or RHI?
On trailing P/E, ABM Industries Incorporated (ABM) is the cheapest at 15.
5x versus Cintas Corporation at 37. 9x. On forward P/E, ManpowerGroup Inc. is actually cheaper at 8. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ABM Industries Incorporated wins at 0. 04x versus Cintas Corporation's 2. 04x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ABM or KELYA or MAN or CTAS or RHI?
Over the past 5 years, Cintas Corporation (CTAS) delivered a total return of +92.
4%, compared to -65. 5% for ManpowerGroup Inc. (MAN). Over 10 years, the gap is even starker: CTAS returned +671. 6% versus KELYA's -32. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ABM or KELYA or MAN or CTAS or RHI?
By beta (market sensitivity over 5 years), Cintas Corporation (CTAS) is the lower-risk stock at 0.
51β versus Kelly Services, Inc. 's 0. 96β — meaning KELYA is approximately 89% more volatile than CTAS relative to the S&P 500. On balance sheet safety, Kelly Services, Inc. (KELYA) carries a lower debt/equity ratio of 16% versus 116% for ManpowerGroup Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ABM or KELYA or MAN or CTAS or RHI?
By revenue growth (latest reported year), Cintas Corporation (CTAS) is pulling ahead at 7.
7% versus -7. 2% for Robert Half International Inc. (RHI). On earnings-per-share growth, the picture is similar: ABM Industries Incorporated grew EPS 102. 3% year-over-year, compared to -427. 4% for Kelly Services, Inc.. Over a 3-year CAGR, CTAS leads at 9. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ABM or KELYA or MAN or CTAS or RHI?
Cintas Corporation (CTAS) is the more profitable company, earning 17.
5% net margin versus -6. 0% for Kelly Services, Inc. — meaning it keeps 17. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTAS leads at 22. 8% versus -1. 6% for KELYA. At the gross margin level — before operating expenses — CTAS leads at 50. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ABM or KELYA or MAN or CTAS or RHI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ABM Industries Incorporated (ABM) is the more undervalued stock at a PEG of 0. 04x versus Cintas Corporation's 2. 04x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ManpowerGroup Inc. (MAN) trades at 8. 1x forward P/E versus 34. 1x for Cintas Corporation — 26. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KELYA: 52. 0% to $15. 00.
08Which pays a better dividend — ABM or KELYA or MAN or CTAS or RHI?
All stocks in this comparison pay dividends.
Robert Half International Inc. (RHI) offers the highest yield at 8. 8%, versus 0. 9% for Cintas Corporation (CTAS).
09Is ABM or KELYA or MAN or CTAS or RHI better for a retirement portfolio?
For long-horizon retirement investors, Cintas Corporation (CTAS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
51), 0. 9% yield, +671. 6% 10Y return). Both have compounded well over 10 years (CTAS: +671. 6%, KELYA: -32. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ABM and KELYA and MAN and CTAS and RHI?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ABM is a small-cap deep-value stock; KELYA is a small-cap income-oriented stock; MAN is a small-cap income-oriented stock; CTAS is a mid-cap quality compounder stock; RHI is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.